ArticleHaematologica2017

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.

Douglas B Cines et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.